01-01-1970 12:00 AM | Source: Accord Fintech
Supriya Lifescience lists with 55.11% premium on the BSE
Supriya Lifescience has debuted at Rs 425.00 on the BSE, up by 151 points or 55.11% from its issue price of Rs 274.
The scrip is currently trading at Rs 396.90, up by 122.90 points or 44.85% from its issue price. It has touched a high and low of Rs 425.00 and Rs 388.20 respectively. So far 5.67 lakh shares were traded on the counter.
The offering, which was open for subscription between December 16, 2021 and December 20, 2021, was subscribed 71.51 times. The issue price was fixed at Rs 274 per share i.e. at upper end of price band of Rs 265-274 apiece.
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.
Latest News
BFSI, flex spaces key demand drivers for office spac...
Buy Kolte Patil Developers Ltd For Target Rs.525 By ...
Global private equity firm TA makes strategic invest...
Indian aviation sector sets new record with over 5 l...
Proactively monitor portfolios to address potential ...
Exploring Indian Tourism: A Journey Through Diversity
Unemployment rate dips to 6.4% in Q2FY25: PLFS data
Sell Hindalco Industries Ltd For Target Rs.600 By Em...
Century Plyboards (India) surges on hiking sharehold...
Reduce Hyundai Motor India Ltd For Target Rs.1,750 B...